LumiThera Acquires MacuLogix Assets (AdaptDx Pro)

LumiThera Acquires Diopsys

November 11, 2021

Medical Devices

LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.

Somatus Acquires Strategic Assets from Lumiata

April 28, 2022

Healthcare Services

Somatus has acquired strategic assets from Lumiata to integrate Lumiata's healthcare AI and predictive analytics into Somatus' RenalIQ platform, improving early identification of people with chronic kidney disease and prediction of disease progression. The deal brings Lumiata talent (including Jessica McCarthy) into Somatus and aims to strengthen care delivery, reduce costs for provider and health-plan partners, and address health inequities.

DiscernDx Acquires Luminist Labs

April 29, 2020

Biotechnology

DiscernDx, a Palo Alto precision medicine company, has acquired Luminist Labs, a privately-held diagnostic platform developer focused on early detection and diagnosis of liver disease. The acquisition will integrate Luminist's data and platform into DiscernDx's multi-omics system to accelerate development of non-invasive diagnostic and prognostic solutions for NASH and other chronic metabolic liver diseases. Terms were not disclosed.

AdaptHealth Acquires Solara Medical Supplies from Linden Capital Partners

May 26, 2020

Healthcare Services

AdaptHealth Corp. has agreed to acquire Solara Medical Supplies, LLC from Linden Capital Partners, adding the largest independent U.S. distributor of continuous glucose monitors and other diabetes supplies to AdaptHealth's in-home medical supplies platform. The transaction is being funded with a combination of debt and equity commitments (including investments from One Equity Partners and Deerfield Management) and will see Solara's CEO Steve Foreman join AdaptHealth's leadership team.

Caldera Medical Acquires UVision 360 and the LUMINELLE Product Family

October 8, 2024

Medical Devices

Caldera Medical has acquired UVision 360, the developer of the LUMINELLE hysteroscopy and cystoscopy systems, expanding its minimally invasive women's health device portfolio. The deal brings the LUMINELLE product family — including the new LUMINELLE Bx on-demand biopsy technology — into Caldera's commercial infrastructure to broaden office-based and surgical hysteroscopy capabilities.

Avance Clinical Acquires U.S.-Based LumaBridge

January 7, 2026

Healthcare Services

Avance Clinical, an Australian full‑service CRO, has acquired LumaBridge, a U.S.-based oncology-focused clinical research organization. The deal expands Avance's U.S. footprint and establishes LumaBridge as the foundation of Avance's global Oncology Center of Excellence, strengthening oncology clinical trial capabilities from early‑phase through later‑phase programs.